MED vs. GPC

Last updated Apr 1, 2026

Compare and contrast key facts about Medifast, Inc. (MED) and Genuine Parts Company (GPC).

Performance

MED vs. GPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and Genuine Parts Company (GPC). The values are adjusted to include any dividend payments, if applicable.

MED vs. GPC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MED Medifast, Inc.	-4.59%	-39.39%	-73.79%	-38.34%	-42.31%	9.36%	86.18%	-9.73%	82.11%	72.33%
GPC Genuine Parts Company	-13.21%	8.70%	-13.22%	-18.12%	26.82%	43.39%	-2.19%	14.05%	4.11%	2.45%

Fundamentals

Market Cap MED : $112.00M GPC : $14.69B
EPS MED : -$1.70 GPC : $0.47
PS Ratio MED : 0.29 GPC : 0.61
PB Ratio MED : 0.56 GPC : 3.32
Total Revenue (TTM) MED : $385.79M GPC : $24.30B
Gross Profit (TTM) MED : $275.19M GPC : $8.94B
EBITDA (TTM) MED : $1.45M GPC : $753.70M

Returns By Period

In the year-to-date period, MED achieves a -4.59% return, which is significantly higher than GPC's -13.21% return. Over the past 10 years, MED has underperformed GPC with an annualized return of -7.88%, while GPC has yielded a comparatively higher 3.55% annualized return.

MED

• 1D: 2.00%
• 1M: -3.23%
• YTD: -4.59%
• 6M: -25.46%
• 1Y: -24.41%
• 3Y*: -53.24%
• 5Y*: -44.69%
• 10Y*: -7.88%

GPC

• 1D: 1.34%
• 1M: -10.52%
• YTD: -13.21%
• 6M: -22.39%
• 1Y: -8.30%
• 3Y*: -11.58%
• 5Y*: 0.82%
• 10Y*: 3.55%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MED vs. GPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED

MED Risk / Return Rank: 16
MED Sharpe Ratio Rank: 14
MED Sortino Ratio Rank: 15
MED Omega Ratio Rank: 17
MED Calmar Ratio Rank: 18
MED Martin Ratio Rank: 14

GPC

GPC Risk / Return Rank: 30
GPC Sharpe Ratio Rank: 29
GPC Sortino Ratio Rank: 26
GPC Omega Ratio Rank: 26
GPC Calmar Ratio Rank: 35
GPC Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MED vs. GPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and Genuine Parts Company (GPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MED	GPC	Difference
Sharpe ratio Return per unit of total volatility	-0.64	-0.28	-0.36
Sortino ratio Return per unit of downside risk	-0.75	-0.19	-0.56
Omega ratio Gain probability vs. loss probability	0.92	0.97	-0.06
Calmar ratio Return relative to maximum drawdown	-0.70	-0.22	-0.48
Martin ratio Return relative to average drawdown	-1.37	-0.72	-0.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MED vs. GPC - Sharpe Ratio Comparison

The current MED Sharpe Ratio is -0.64, which is lower than the GPC Sharpe Ratio of -0.28. The chart below compares the historical Sharpe Ratios of MED and GPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	MED	GPC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.64	-0.28	-0.36
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-1.00	0.03	-1.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.17	0.13	-0.30
Sharpe Ratio (All Time) Calculated using the full available price history	0.03	0.38	-0.36

Correlation

The correlation between MED and GPC is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MED vs. GPC - Dividend Comparison

MED has not paid dividends to shareholders, while GPC's dividend yield for the trailing twelve months is around 3.93%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MED Medifast, Inc.	0.00%	0.00%	0.00%	7.36%	5.69%	2.71%	2.30%	3.08%	1.75%	2.06%	2.57%	0.82%
GPC Genuine Parts Company	3.93%	3.35%	3.43%	2.74%	2.06%	2.33%	3.15%	2.87%	3.00%	2.84%	2.75%	2.86%

Drawdowns

MED vs. GPC - Drawdown Comparison

The maximum MED drawdown since its inception was -98.40%, which is greater than GPC's maximum drawdown of -54.89%. Use the drawdown chart below to compare losses from any high point for MED and GPC.

Drawdown Indicators

	MED	GPC	Difference
Max Drawdown Largest peak-to-trough decline	-98.40%	-54.89%	-43.51%
Max Drawdown (1Y) Largest decline over 1 year	-37.39%	-34.84%	-2.55%
Max Drawdown (5Y) Largest decline over 5 years	-96.76%	-43.40%	-53.36%
Max Drawdown (10Y) Largest decline over 10 years	-96.76%	-54.89%	-41.87%
Current Drawdown Current decline from peak	-96.54%	-37.90%	-58.64%
Average Drawdown Average peak-to-trough decline	-50.56%	-10.17%	-40.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.18%	10.77%	+8.41%

Volatility

MED vs. GPC - Volatility Comparison

Medifast, Inc. (MED) has a higher volatility of 12.03% compared to Genuine Parts Company (GPC) at 8.83%. This indicates that MED's price experiences larger fluctuations and is considered to be riskier than GPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MED	GPC	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.03%	8.83%	+3.20%
Volatility (6M) Calculated over the trailing 6-month period	24.44%	23.36%	+1.08%
Volatility (1Y) Calculated over the trailing 1-year period	38.63%	29.91%	+8.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.85%	26.62%	+18.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	47.09%	27.93%	+19.16%

Financials

MED vs. GPC - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and Genuine Parts Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Medifast, Inc. reported a gross profit of 52.14M and revenue of 75.10M. Therefore, the gross margin over that period was 69.4%.

GPC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Genuine Parts Company reported a gross profit of 2.10B and revenue of 6.01B. Therefore, the gross margin over that period was 35.0%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Medifast, Inc. reported an operating income of -7.80M and revenue of 75.10M, resulting in an operating margin of -10.4%.

GPC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Genuine Parts Company reported an operating income of -38.43M and revenue of 6.01B, resulting in an operating margin of -0.6%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Medifast, Inc. reported a net income of -18.12M and revenue of 75.10M, resulting in a net margin of -24.1%.

GPC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Genuine Parts Company reported a net income of -609.50M and revenue of 6.01B, resulting in a net margin of -10.1%.